Creating Waves of Awareness
The active ingredient in vinegar, acetic acid, can effectively kill mycobacteria, even highly drug-resistant Mycobacterium tuberculosis, an international team of researchers from Venezuela, France, and the US reports in mBio®, the online open-access journal of the American Society for Microbiology.
Acetic acid might be used as an inexpensive and non-toxic disinfectant against drug-resistant tuberculosis (TB) bacteria as well as other stubborn, disinfectant-resistant mycobacteria.
Abstract Source Acetic Acid, the Active Component of Vingegar, Is an Effective Tuberculocidal Disinfectant
Effective and economical mycobactericidal disinfectants are needed to kill bothMycobacterium tuberculosis and non-M. tuberculosis mycobacteria. We found that acetic acid (vinegar) efficiently kills M. tuberculosis after 30 min of exposure to a 6% acetic acid solution. The activity is not due to pH alone, and propionic acid also appears to be bactericidal. M. bolletii and M. massiliensenontuberculous mycobacteria were more resistant, although a 30-min exposure to 10% acetic acid resulted in at least a 6-log10 reduction of viable bacteria. Acetic acid (vinegar) is an effective mycobactericidal disinfectant that should also be active against most other bacteria. These findings are consistent with and extend the results of studies performed in the early and mid-20th century on the disinfectant capacity of organic acids.
Tuberculosis is becoming concentrated among immigrants, drug addicts, and the poor and homeless in Western Europe's big cities despite progress in reducing national rates of the disease, experts said on Friday.
The contagious lung infection, once known as the "white plague" for its ability to render its victims pale, skinny and feverish, is being well tackled at national levels, they said, but is persisting in high-risk, marginalized groups.
In a study of European Union (EU) cities with populations of more than 500,000, the researchers found that on average the rate of tuberculosis (TB) in big cities was twice the rate of the national TB incidence.
The commemoration of World TB Day seeks to raise awareness on the tuberculosis burden in the world, as well as the efforts made for its prevention and control. Throughout the years, this commemoration has offered the opportunity to mobilize the political, economic and social commitment for the prevention and control of TB in the countries.
Drug resistance and the HIV pandemic have thwarted efforts to rid the world of humanity's biggest killer Mycobacterium tuberculosis. We need new types of safe drug, a practical point-of-care diagnostic and ultimately an effective vaccine if we are ever to eliminate tuberculosis. But first we need a better understanding of the underlying biology.
ROCKVILLE, MD, USA & CAPE TOWN, ZA, March 11, 2014 – Aeras today announced the initiation of the first randomized, controlled tuberculosis (TB) vaccine trial designed to study prevention of Mycobacterium tuberculosis (Mtb) infection by vaccination. The Phase II study of the TB vaccine candidate, H4+IC31® (AERAS-404), will evaluate its safety, immunogenicity, and ability to prevent infection by Mtb, the bacterium that causes TB. The trial, which will be conducted in South Africa, will also evaluate BCG revaccination. Bacille Calmette-Guerin (BCG), the current TB vaccine, is one of the most widely administered vaccines globally. It prevents some forms of TB in children, but its widespread use in infants has failed to control the global epidemic.
China COPD and Tuberculosis
In China however, thousands of non-smokers shows signs of non-reversible airways obstruction - and the reasons seem to be the country's ubiquitous use of dirty coal for cooking and heating. A study of 300,000 Chinese adults who have never smoked has found that one in twenty (5%) have COPD, with the condition more common in women than in men.
The main factors associated with COPD were low income, lack of education, living in a rural area and a prior history of tuberculosis. However, another major factor was cooking with coal.
The study researchers, from the Chinese Academy of Medical Sciences, Beijing, and Oxford university, said the link between low income and lung disease might be due to higher exposure to infections and to air pollution.
The findings are published in the European Respiratory Journal.
BMC| Scientific Abstracts Presented at the International Research Congress on Integrative Medicine and Health 2012
P02.167. Long term evaluation of homeopathy on post treatment impairment of pulmonary tuberculosis submitted by S
Sharma and N Sharma
1 NMP Medical Research Institute, Jaipur, India
2 Brett Research (UK), London, United Kingdom
BMC Complementary and Alternative Medicine 2012, 12(Suppl 1):P223 doi:10.1186/1472-6882-12-S1-P223
Published: June 12, 2012
The researchers in search of patient care after tuberculosis dysfunction evaluated the use of homeopathy. Use of the gold standard evidence-based method of double-blind placebo-controlled trial studied a group of cured TB patients to assess their health using specific criteria of body functions including: cough, breathing capacity, body weight, and quality of life. This trial showed positive effectiveness for the use of homeopathy in Tuberculosis patients.
WHO Warns Patients To Stay Away From Homeopathy
Homeopathy The Answer To Indiscriminate Use Of Antibiotics